The occurrence of PIK3CA mutations was explored both in in situ and in invasive breast cancers and the conclusion was reached that its frequency is similar in these two tumors, thus supporting the concept that it is more likely to play a role in breast tumor initiation than in invasive progression [38]. The gene discussed is PIK3CA; the disease is invasive breast carcinoma.